Rituxan (Rituximab) for Rheumatoid Arthritis and Non-Hodgkins Lymphoma
Links shared publicly online about this topic.
- 1,611total visits
Rituxan (Rituximab) for Rheumatoid Arthritis and Non-Hodgkins Lymphoma
View full resource at rituxan.com
Tags: Lymphoma, Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma Medication, Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Rituxan, MabThera
Most Recently Shared on March 8, 2010 at 7:41 pm By:
Rituxan generally indicated for RA when when the use of 1+TNF antagonist drug response is inadequate http://www.rituxan.com/
New vasculitis therapy: Researchers find new therapy for vasculitis - latimes.com
latimes.com — “Forty years after the development of the only therapy for vasculitis, a rare but severe disease of blood vessels, researchers have found a new therapy that is at least as effective, requires fewer treatments and promises far fewer side effects. Federally-funded researchers reported Wednesday that treatment with the biotech drug rituximab, already marketed as Rituxan for the treatment of B cell lymphoma and rheumatoid arthritis, is slightly more effective than the existing drug, cyclophosphamide,” View full resource at latimes.com
Most Recently Shared on July 15, 2010 at 8:20 pm By:
Monica R.Gaidhane Doctor and Physician
New vasculitis therapy: Researchers find new therapy for vasculitis - latimes.com http://bit.ly/aHnDxU
Avoiding Infertility And Cancer With New Therapy For Vasculitis
medicalnewstoday.com — “Researchers have identified that rituxan, a drug previously approved for the treatment of non-hodgkin's b cell lymphoma and rheumatoid arthritis, can treat severe anca-associated vasculitis as eff” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2009 at 11:39 am By:
Avoiding Infertility And Cancer With New Therapy For Vasculitis: Researchers have identified that Rituxan, a dru.. http://bit.ly/3zU0EY
New therapy for vasculitis will help patients avoid infertility and cancer
physorg.com — “Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy. The news will be presented October 18 at the ...” View full resource at physorg.com
Most Recently Shared on October 18, 2009 at 3:05 pm By:
New therapy for vasculitis will help patients avoid infertility and cancer http://bit.ly/3jGMoP
Advertisement
